One of the main characteristics of MDSCs is their ability to suppress anti-tumor T cell activity [1], so we next tested whether crosslinking CD79a has an effect on inhibition of T cell proliferation by BM myeloid cells. This evidence concerns the gene CD79A and neoplasm.